New price proposal of Gleevec on sharp backlash

Published: 2002-03-08 07:00:00

Updated: 2002-03-08 07:00:00

The Joint Counter Measure Council for Gleevec Pricing and Expansion of Drug Public Benefits (hereinafter called Gleevec Pricing Council: GPC), a civic organization for fighting against Norvatis' Gleevec pricing policy, responded with a harsh backlash against which Norvatis Korea proposed a new pr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK